Figure 4.

Time to achieve the first Hb ≥10.0 g/dL per patient according to starting-dose group. Patients starting with Hb ≥10.0 g/dL were not included in this graph because the event of interest (Hb ≥10.0 g/dL) has already happened (left censored). Patients who never achieved Hb ≥10.0 g/dL after treatment were annotated with a “+” sign on the graph (right censored). No patients with a starting dose of ≤1 µg/kg/4 wk achieved Hb ≥10.0 g/dL without dose adjustments. No dose group resulted in Hb ≥10.0 g/dL significantly faster (p = 0.630).

Hb, hemoglobin.